Teva Pharmaceutical Industries Ltd. TEVA today announced that the company has filed a Citizen Petition with the U.S. Food and Drug Administration requesting that the FDA refuse to approve any abbreviated new drug application for a purported generic version of COPAXONE.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
